Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study

<p>Abstract</p> <p>Background</p> <p>Our aim was to compare the effects of a Paleolithic ('Old Stone Age') diet and a diabetes diet as generally recommended on risk factors for cardiovascular disease in patients with type 2 diabetes not treated with insulin.&l...

Full description

Bibliographic Details
Main Authors: Hansson Anita, Pålsson Gunvor, Branell Ulla-Carin, Ahrén Bo, Granfeldt Yvonne, Jönsson Tommy, Söderström Margareta, Lindeberg Staffan
Format: Article
Language:English
Published: BMC 2009-07-01
Series:Cardiovascular Diabetology
Online Access:http://www.cardiab.com/content/8/1/35
id doaj-33bb2ef85a8541ef8ed865e4f49e141f
record_format Article
spelling doaj-33bb2ef85a8541ef8ed865e4f49e141f2020-11-25T01:58:21ZengBMCCardiovascular Diabetology1475-28402009-07-01813510.1186/1475-2840-8-35Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot studyHansson AnitaPålsson GunvorBranell Ulla-CarinAhrén BoGranfeldt YvonneJönsson TommySöderström MargaretaLindeberg Staffan<p>Abstract</p> <p>Background</p> <p>Our aim was to compare the effects of a Paleolithic ('Old Stone Age') diet and a diabetes diet as generally recommended on risk factors for cardiovascular disease in patients with type 2 diabetes not treated with insulin.</p> <p>Methods</p> <p>In a randomized cross-over study, 13 patients with type 2 diabetes, 3 women and 10 men, were instructed to eat a Paleolithic diet based on lean meat, fish, fruits, vegetables, root vegetables, eggs and nuts; and a Diabetes diet designed in accordance with dietary guidelines during two consecutive 3-month periods. Outcome variables included changes in weight, waist circumference, serum lipids, C-reactive protein, blood pressure, glycated haemoglobin (HbA1c), and areas under the curve for plasma glucose and plasma insulin in the 75 g oral glucose tolerance test. Dietary intake was evaluated by use of 4-day weighed food records.</p> <p>Results</p> <p>Study participants had on average a diabetes duration of 9 years, a mean HbA1c of 6,6% units by Mono-S standard and were usually treated with metformin alone (3 subjects) or metformin in combination with a sulfonylurea (3 subjects) or a thiazolidinedione (3 subjects). Mean average dose of metformin was 1031 mg per day. Compared to the diabetes diet, the Paleolithic diet resulted in lower mean values of HbA1c (-0.4% units, <it>p </it>= 0.01), triacylglycerol (-0.4 mmol/L, <it>p </it>= 0.003), diastolic blood pressure (-4 mmHg, <it>p </it>= 0.03), weight (-3 kg, <it>p </it>= 0.01), BMI (-1 kg/m<sup>2</sup>, <it>p </it>= 0.04) and waist circumference (-4 cm, <it>p </it>= 0.02), and higher mean values of high density lipoprotein cholesterol (+0.08 mmol/L, <it>p </it>= 0.03). The Paleolithic diet was mainly lower in cereals and dairy products, and higher in fruits, vegetables, meat and eggs, as compared with the Diabetes diet. Further, the Paleolithic diet was lower in total energy, energy density, carbohydrate, dietary glycemic load, saturated fatty acids and calcium, and higher in unsaturated fatty acids, dietary cholesterol and several vitamins. Dietary GI was slightly lower in the Paleolithic diet (GI = 50) than in the Diabetic diet (GI = 55).</p> <p>Conclusion</p> <p>Over a 3-month study period, a Paleolithic diet improved glycemic control and several cardiovascular risk factors compared to a Diabetes diet in patients with type 2 diabetes.</p> <p>Trial registration</p> <p>ClinicalTrials.gov NCT00435240.</p> http://www.cardiab.com/content/8/1/35
collection DOAJ
language English
format Article
sources DOAJ
author Hansson Anita
Pålsson Gunvor
Branell Ulla-Carin
Ahrén Bo
Granfeldt Yvonne
Jönsson Tommy
Söderström Margareta
Lindeberg Staffan
spellingShingle Hansson Anita
Pålsson Gunvor
Branell Ulla-Carin
Ahrén Bo
Granfeldt Yvonne
Jönsson Tommy
Söderström Margareta
Lindeberg Staffan
Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study
Cardiovascular Diabetology
author_facet Hansson Anita
Pålsson Gunvor
Branell Ulla-Carin
Ahrén Bo
Granfeldt Yvonne
Jönsson Tommy
Söderström Margareta
Lindeberg Staffan
author_sort Hansson Anita
title Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study
title_short Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study
title_full Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study
title_fullStr Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study
title_full_unstemmed Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study
title_sort beneficial effects of a paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study
publisher BMC
series Cardiovascular Diabetology
issn 1475-2840
publishDate 2009-07-01
description <p>Abstract</p> <p>Background</p> <p>Our aim was to compare the effects of a Paleolithic ('Old Stone Age') diet and a diabetes diet as generally recommended on risk factors for cardiovascular disease in patients with type 2 diabetes not treated with insulin.</p> <p>Methods</p> <p>In a randomized cross-over study, 13 patients with type 2 diabetes, 3 women and 10 men, were instructed to eat a Paleolithic diet based on lean meat, fish, fruits, vegetables, root vegetables, eggs and nuts; and a Diabetes diet designed in accordance with dietary guidelines during two consecutive 3-month periods. Outcome variables included changes in weight, waist circumference, serum lipids, C-reactive protein, blood pressure, glycated haemoglobin (HbA1c), and areas under the curve for plasma glucose and plasma insulin in the 75 g oral glucose tolerance test. Dietary intake was evaluated by use of 4-day weighed food records.</p> <p>Results</p> <p>Study participants had on average a diabetes duration of 9 years, a mean HbA1c of 6,6% units by Mono-S standard and were usually treated with metformin alone (3 subjects) or metformin in combination with a sulfonylurea (3 subjects) or a thiazolidinedione (3 subjects). Mean average dose of metformin was 1031 mg per day. Compared to the diabetes diet, the Paleolithic diet resulted in lower mean values of HbA1c (-0.4% units, <it>p </it>= 0.01), triacylglycerol (-0.4 mmol/L, <it>p </it>= 0.003), diastolic blood pressure (-4 mmHg, <it>p </it>= 0.03), weight (-3 kg, <it>p </it>= 0.01), BMI (-1 kg/m<sup>2</sup>, <it>p </it>= 0.04) and waist circumference (-4 cm, <it>p </it>= 0.02), and higher mean values of high density lipoprotein cholesterol (+0.08 mmol/L, <it>p </it>= 0.03). The Paleolithic diet was mainly lower in cereals and dairy products, and higher in fruits, vegetables, meat and eggs, as compared with the Diabetes diet. Further, the Paleolithic diet was lower in total energy, energy density, carbohydrate, dietary glycemic load, saturated fatty acids and calcium, and higher in unsaturated fatty acids, dietary cholesterol and several vitamins. Dietary GI was slightly lower in the Paleolithic diet (GI = 50) than in the Diabetic diet (GI = 55).</p> <p>Conclusion</p> <p>Over a 3-month study period, a Paleolithic diet improved glycemic control and several cardiovascular risk factors compared to a Diabetes diet in patients with type 2 diabetes.</p> <p>Trial registration</p> <p>ClinicalTrials.gov NCT00435240.</p>
url http://www.cardiab.com/content/8/1/35
work_keys_str_mv AT hanssonanita beneficialeffectsofapaleolithicdietoncardiovascularriskfactorsintype2diabetesarandomizedcrossoverpilotstudy
AT palssongunvor beneficialeffectsofapaleolithicdietoncardiovascularriskfactorsintype2diabetesarandomizedcrossoverpilotstudy
AT branellullacarin beneficialeffectsofapaleolithicdietoncardiovascularriskfactorsintype2diabetesarandomizedcrossoverpilotstudy
AT ahrenbo beneficialeffectsofapaleolithicdietoncardiovascularriskfactorsintype2diabetesarandomizedcrossoverpilotstudy
AT granfeldtyvonne beneficialeffectsofapaleolithicdietoncardiovascularriskfactorsintype2diabetesarandomizedcrossoverpilotstudy
AT jonssontommy beneficialeffectsofapaleolithicdietoncardiovascularriskfactorsintype2diabetesarandomizedcrossoverpilotstudy
AT soderstrommargareta beneficialeffectsofapaleolithicdietoncardiovascularriskfactorsintype2diabetesarandomizedcrossoverpilotstudy
AT lindebergstaffan beneficialeffectsofapaleolithicdietoncardiovascularriskfactorsintype2diabetesarandomizedcrossoverpilotstudy
_version_ 1724970201862111232